Atlas Trials

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Clinical trial NCT00372983 · COMPLETED

Trial details

NCT number
NCT00372983
Sponsor
Cellectar Biosciences, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis C
Start date
2006-08-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.